Study to Assess Change in Disease Activity and Adverse Events of RINVOQ in Adult Participants With Ankylosing Spondylitis in the Real-World Japan
Clinical trial NCT05609643 · COMPLETED
Trial details
- NCT number
- NCT05609643
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-06
- Primary completion
- 2025-12-11
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.